Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 1, 1996
Biological responses differ considerably between endovascular and conventional aortic aneurysm surgeryP Swartbol, L Norgren, U Albrechtsson, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1992
Digital luminescence radiography using a chest phantom. Comparison between radiographs displayed on monitor and hard-copyM Kehler, U Albrechtsson, E Arnadóttir, et al.
Acta Medica Scandinavica|January 1, 1987
Incidence of deep vein thrombosis in bedridden non-surgical patientsA Kierkegaard, L Norgren, C G Olsson, et al.
Thrombosis Research|July 19, 2000
Correlation between different intensities of anti-vitamin K treatment and coagulation parametersA Jerkeman, J Astermark, U Hedner, et al.
Thrombosis and Haemostasis|August 1, 1996
Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosisJ N Fiessinger, M Lopez-Fernandez, E Gatterer, et al.
Lancet (London, England)|September 3, 1988
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)R G Wilcox, G von der Lippe, C G Olsson, et al.
Lancet (London, England)|May 19, 1990
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early ThrombolysisR G Wilcox, G von der Lippe, C G Olsson, et al.
The Annals of Thoracic Surgery|May 22, 1998
Successful thrombolysis of an occluded modified Blalock shunt three days after operationT K Malm, C Holmqvist, C G Olsson, et al.
Circulation|February 1, 1988
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolismM Verstraete, G A Miller, H Bounameaux, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Pageof 9